Virological and immunological outcomes of elvitegravir-based regimen in a treatment-naïve HIV-2-infected patient

AIDS. 2014 Sep 24;28(15):2329-31. doi: 10.1097/QAD.0000000000000414.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • CD4 Lymphocyte Count
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV-2 / isolation & purification*
  • Humans
  • Male
  • Middle Aged
  • Quinolones / therapeutic use*
  • Time Factors
  • Treatment Outcome
  • Viral Load*

Substances

  • Anti-HIV Agents
  • Quinolones
  • elvitegravir